Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

UFS researcher engineers metal surfaces
2015-03-03

Shaun Cronjé, a PhD student, in a surface characterisation laboratory at the UFS.

It is well known that the surface of a component is much more vulnerable to damage than the interior, and that surface-originated degradation such as wear, corrosion, and fracture will eventually destroy the component.

“Engineering the surface, based on scientific knowledge, is essential to control these damaging processes. It also creates electronic and geometric structures on the surface which opens up a world of new devices, especially considering the properties on the nano-length scale,” said Prof Wiets Roos from the Department of Physics at the University of the Free State (UFS).

At elevated temperatures, atoms are more mobile and can migrate to grain boundaries and surfaces, which have a major influence on material properties. The redistribution of solute atoms between the surface and the bulk of the material is known as segregation. Knowing the behaviour of segregation at the surface/environment interface can be very useful in the development of new materials. As an example materials can be improved higher efficiency and lower fuel consumption, thus reducing environmental pollution.

The main aims of Prof Roos’s research are to understand surface segregation, use it as a tool, and contribute to the various surface engineering fields.

The surface characterisation laboratories at the UFS are well equipped to do high temperature segregation measurements, and have already proven a success, not only in the ability to prepare the specimens for characterisation, but also in developing models and procedures to quantify the segregation parameters.

The most recent results have demonstrated the importance of taking evaporation into account during quantification.” This has laid the foundation for future studies by installing the necessary hardware in a surface characterisation spectrometer, establishing experimental protocols, and improving an existing model (developed in this laboratory) for simulating segregation profiles,” said Prof Roos.

Segregation parameters allow the researcher to predict and utilise the surface concentration behaviour as a function of temperature and time. “This not only contributes to fields involving corrosion, oxidation, sintering, wear, chemical poisoning, powder metallurgy, and lubrication but adds to the development of self-healing devices,” said Prof Roos.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept